Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
We Think Moderna Still Has A Future
04:56pm, Tuesday, 22'nd Oct 2024
Moderna, Inc.'s share price has weakened due to declining COVID-19 vaccine demand, but its diverse asset portfolio supports future growth and returns. The company is focusing on respiratory vaccines,
Why Moderna (MRNA) Dipped More Than Broader Market Today
06:56pm, Monday, 21'st Oct 2024
Moderna (MRNA) reachead $53.80 at the closing of the latest trading day, reflecting a -0.55% change compared to its last close.
Top 7 Tax-Loss Stocks To Sell By October 31, 2024
08:25am, Monday, 21'st Oct 2024
Wolfspeed rallied due to a $750 million investment from Apollo Global Management, despite high short interest and bearish sentiment. SolarEdge Technologies faces significant competition and high inven
Don't Get Caught Holding 7 Stocks About To Shrink 30% Or More
08:00am, Monday, 21'st Oct 2024
Earnings season for most S&P 500 companies is a time to post impressive growth. But a cohort of companies is about to shrink.
Health Rounds: mRNA vaccine shows promise against C. difficile in animal study
01:26pm, Friday, 18'th Oct 2024
Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to-treat Clostridioides difficile bacteria, using the technology behind the r
Moderna to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
07:05am, Thursday, 17'th Oct 2024
CAMBRIDGE, MA / ACCESSWIRE / October 17, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 7, 2024 to repor
3 Vaccine Stocks to Watch as Flu Season Approaches
02:54pm, Wednesday, 16'th Oct 2024
Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring.
Moderna Stock Falls 20% in a Month: Time to Sell or Hold?
10:51am, Wednesday, 16'th Oct 2024
Shares of MRNA have been declining after it lowered its long-term financial guidance. It has also pushed its breakeven point by another two years to 2028.
GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines
10:20am, Tuesday, 15'th Oct 2024
GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Tuesday, 15'th Oct 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The mRNA therapeutics market size has grown steadily in
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
06:56pm, Monday, 14'th Oct 2024
The latest trading day saw Moderna (MRNA) settling at $57.73, representing a -0.96% change from its previous close.
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "mRNA Cancer Vaccines and Therapeutics Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The mRNA cancer vaccines and therap
2 Biotech Stocks That Are Screaming Buys This Month
08:30am, Saturday, 12'th Oct 2024
They won't remain southbound forever.
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
06:55pm, Tuesday, 08'th Oct 2024
Moderna (MRNA) concluded the recent trading session at $58.39, signifying a -0.56% move from its prior day's close.
